- SEK1.81bn
- SEK3.49bn
- SEK8.42bn
Brief: Volati Proposes Dividend Of SEK 10 Per Ordinary Share
Brief: Volati Provides Clarification On Future Dividends
Brief: Volati Divests Naturamed Pharma, Closes Consumer Business Area
Brief: Volati Q3 EBITA Up At SEK 157 Million
Brief: Volati Divests Besikta Bilprovning With An Estimated Capital Gain Of SEK 750 Million
Brief: Volati Acquires Märkas AB
Brief: Volati Acquires Pisla Oy
Brief: Volati Q2 EBITA Rises To SEK 181 Million
Brief: Volati Preliminary Q2 EBITA Up At SEK 181 Mln
Brief: Volati Continues Its Growth With Acquisition Of Beneli
Brief: Volati Board Recommends That No Dividend Be Paid To Preference And Ordinary Shareholders
Brief: Volati AB - Q1 Net Sales Sek 1,658 Million
Brief: Volati Announces Preliminary Results For Q1 2020
Brief: Volati Provides Update On The Coronavirus Impact
Brief: Volati AB Volati Board Proposes No Dividend To Ordinary Shareholders
Brief: Volati Presents New Financial Targets
Brief: Volati Q4 EBITDA Rises To SEK 291 Mln
Brief: Volati Acquires Heco Nordiska
Brief: Volati Acquires All Of Shares In Swekip Sweden